Dr. Jay Bhaumik has seen, in real time, how the American healthcare conversation continues to shift. Among the most consequential of those shifts has been patients discovering how compounded medications, for many, are a permanent answer to their medication needs.
What was once a practical workaround during widespread pharmaceutical shortages has taken its place as a meaningful, lasting segment of modern medical care. Patients who once sought out compounding pharmacies out of necessity now choose to remain instead of switching to a standard pharmacy. Understanding why requires a closer look at what compounding offers that mass-manufactured drugs cannot.
What Compounded Medications Are
Compounded medications represent custom-formulated prescriptions prepared by a licensed pharmacist to meet a specific clinical need. Compounding pharmacies do not manufacture drugs in bulk for the general market but instead combine, mix, or alter pharmaceutical ingredients to create tailored medications.
Compounding is often mischaracterized as a lesser version of commercial pharmaceutical production, but that framing misses the mark entirely. Compounded medications are created to fill genuine clinical gaps. Consider a child who cannot swallow a tablet but needs precise blood pressure medication dosages, or a patient with a documented allergy to a dye used in standard commercial formulation. Commercial markets are not designed to meet such individual needs.
The Shortage That Changed the Conversation
The recent GLP-1 receptor agonist shortage brought compounding pharmacies into mainstream visibility with a speed the industry had never seen.
Patients prescribed brand-name diabetes or weight management medications could not access them and turned to compounding pharmacies as an alternative source. This became a first encounter with the compounding model for mange, and the quality of care surrounding the experience surprised a significant portion of those patients.
Compounding pharmacies like those operating under 503B outsourcing facility standards or the 503A state-regulated requirements are working alongside prescribers to individualize therapy in attentive ways standard prescription fills cannot match. Many patients find they prefer the clinical relationship of a compound pharmacy, which allows dosing flexibility, direct pharmacist consultation, and the ability to adjust formulations based on patient response.
Dr. Bhaumik, Chairman of Thesis Pharmacy, has positioned himself amidst investment strategy and pharmaceutical service delivery, watching this play out on a global level.
“The shortage opened a door that a lot of patients didn’t know existed,” he says. “Once they experienced what a compounding pharmacy can actually do, from the customization and relationship with the pharmacist to the ability to fine-tune each medication, many decided they would stick with a compounding facility.”
Clinical Reasons Patients Stay with Compounding
Substantive clinical reasons drive patients to continue compounded medications after commercial alternatives return.
Bioidentical hormone replacement therapy is among the most established examples, as women navigating perimenopause frequently require dosing precision that FDA-approved preparations don’t offer. Compounded estrogen, progesterone, and testosterone formulations can be adjusted incrementally as hormone levels shift.
Dermatology presents another durable use case where conditions like melasma or rosacea require ingredient combinations that none of the single commercial products contain. Topical pain formulations can deliver analgesic compounds locally while avoiding systemic side effects.
“We’re talking about real patients with real conditions that the standard pharmaceutical supply chain wasn’t built to address,” says Dr. Bhaumik. “That’s in no way a criticism of commercial manufacturers, just an honest acknowledgment of what the market optimizes for.”
The Role of the Pharmacist in Long-Term Compounded Care
What distinguishes compounding from a traditional prescription fill is the depth of pharmacist involvement. Compounding pharmacists are trained in formulation science, which includes the chemistry of ingredient interactions, delivery vehicles, and stability.
Patients on long-term compounded medications can develop an ongoing clinical relationship with their pharmacist that mirrors the one they have with their prescribing physician. Continuity matters in chronic disease management, so patients who experience it recognize its worth. Dr. Bhaumik sees this as central to compounding’s lasting appeal.
“The pharmacist is part of the care team, and that’s a different model than most patients are used to. When they experience it, they recognize how much value it adds.”
Regulatory Considerations Patients Should Understand
Patients choosing compounded medications will benefit in the long run from understanding the regulatory framework that governs their care. Compounding pharmacies in the United States operate under either 503A or 503B designations.
Traditional compounding pharmacies operating under 503A state pharmacy board oversight prepare medications for individual patients based on valid prescriptions. Facilities registered under 503B, labeled outsourcing facilities regulated by the FDA, can produce larger batches of compounded medications for use in clinical settings without patient-specific prescriptions, but are subject to current Good Manufacturing Practice standards.
Neither pathway is inherently superior, but the distinctions affect how medications can be sourced, what quality assurance processes apply, and what information patients can expect. Patients committed to long-term compounded therapy should ask their prescribers and pharmacists about the sourcing of their formulations, the quality standards the pharmacy adheres to, and whether the active pharmaceutical ingredients used are obtained from FDA-registered suppliers.
A Shift That Is Here to Stay
For centuries, compounding has existed as a pharmacy practice, long before commercial pharmaceutical manufacturing dominated other models. Recent shortages reminded a generation of patients that alternatives do exist, and that they can be clinically rigorous as well as personally attentive and genuinely superior for specific conditions and populations.
Patients who discovered compounding out of necessity and then chose to remain are making informed decisions grounded in the recognition that their needs are specific. That specificity deserves a response equal to its complexity.
For those in the know, like Dr. Jay Bhaumik, compounded medications are no longer a workaround or stopgap for conventional pharmacies. For millions of patients, they are the right answer to a question that commercial pharmaceutical manufacturing was never designed to ask.
